– IBM and Cleveland Clinic recently announced a 10-year partnership to establish the Discovery Accelerator, which will advance the pace of discovery in healthcare and life sciences through hybrid cloud, artificial intelligence (AI), and quantum computing technologies.
The accelerator is a joint IBM-Cleveland Clinic center that will use advanced computational technology to generate and analyze data to help Cleveland Clinic’s new Global Center for Pathogen Research & Human Health.
The collaboration intends to build robust research and clinical infrastructure to empower big data medical research in ethical ways, while also protecting patient privacy.
Additionally, the companies will work to advance discoveries for patient care and novel approaches to public health threats, such as the COVID-19 pandemic.
“Through this innovative collaboration, we have a unique opportunity to bring the future to life,” Tom Mihaljevic, MD, CEO and president of Cleveland Clinic, said in the announcement.
“These new computing technologies can help revolutionize discovery in the life sciences. The Discovery Accelerator will enable our renowned teams to build a forward-looking digital infrastructure and help transform medicine, while training the workforce of the future and potentially growing our economy,” Mihaljevic continued.
As part of the collaboration, IBM will install its first private-sector, on-premise IBM Quantum System One in the US, which will be located on Cleveland Clinic’s campus. The company will also install the first of IBM’s next-generation qubit quantum systems at a client’s facility.
The quantum program, IBM said, will be designed to engage with universities, government industry, startups, and other organizations. With Cleveland Clinic’s global expertise as the foundation, the program will focus on advancing quantum skills and the core mission of the center.
Quantum-enriched programs can help researchers discover new generations of information technology, fuel advances in science, and provide access to various research and commercial technologies, education, and tools.
“Quantum will make the impossible possible, and when the Governor and I announced the Cleveland Innovation District earlier this year, this was the kind of innovative investment I hoped it would advance,” said Ohio Lieutenant Governor Jon Husted, director of Innovate Ohio.
“A partnership between these two great institutions will put Cleveland, and Ohio, on the map for advanced medical and scientific research, providing a unique opportunity to improve treatment options for patients and solve some of our greatest healthcare challenges,” Husted continued.
The Discovery Accelerator—supported by a $500 million investment from the State of Ohio, Jobs Ohio, and Cleveland Clinic—will serve as the technology foundation for the Global Center for Pathogen Research & Human Health and build upon Cleveland Clinic’s existing programs and expertise.
Specifically, the center will focus on increasing overall understanding of viral pathogens, virus-induced cancers, genomics, single-cell transcriptomics, population health, clinical applications, and chemical and drug discovery.
The center will also engage with world leaders in immunology, cancer biology, immune-oncology, and infectious disease research, as well as technology development and education.
Researchers will expand important work on studying, preparing, and protecting against emerging pathogens and virus-related diseases.
“With high performance computing, hybrid cloud, data, AI, and quantum computing, being used in new ways to break through long-standing bottlenecks in scientific discovery,” said Arvind Krishna, chairman and chief executive officer of IBM.
“Our new collaboration with Cleveland Clinic will combine their world-renowned expertise in healthcare and life sciences with IBM’s next-generation technologies to make scientific discovery faster, and the scope of that discovery larger than ever,” Krishna continued.